JAMES D. RODGERS,ARGYRIOS G. ARVANITIS,JACK GUOEN SHI
申请号:
BRPI0812563
公开号:
BRPI0812563A2
申请日:
2008.06.12
申请国别(地区):
BR
年份:
2015
代理人:
摘要:
The present invention provides active metabolites of 3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.